Model DetailsEye - Harderian gland adenoma
Model Name |
Eye - Harderian gland adenoma | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
Harderian gland, adenoma • Harderian gland adenoma |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Eye - Harderian gland | Male |
9.8% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Male |
15.2% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Female |
9.4% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Female |
11.8% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Male |
7.4% (5 of 68 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Male |
19.4% (13 of 67 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Male |
2.8% (20 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Eye - Harderian gland | Female |
1.5% (11 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Eye - Harderian gland | Male |
10.2% (91 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Eye - Harderian gland | Female |
6.9% (61 of 890 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Eye - Harderian gland | Male |
13% (8 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Eye - Harderian gland | Male |
3.3% (2 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Eye - Harderian gland | Female |
8.3% (5 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Eye - Harderian gland | Female |
8.3% (5 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Eye - Harderian gland | Male |
5.0% (3 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Eye - Harderian gland | Female |
6.7% (4 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Eye - Harderian gland | Female |
1.9% (1 of 54 mice) |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 | |
| Eye - Harderian gland | Male |
1.9% (1 of 52 mice) |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |